Atazanavir and Cardiovascular Risk Among Human Immunodeficiency Virus-Infected Patients: A Systematic Review.

Chow, Dominic; Shikuma, Cecilia; Ritchings, Corey; Guo, Muxing; Rosenblatt, Lisa

Chow, Dominic; Shikuma, Cecilia; Ritchings, Corey; Guo, Muxing; Rosenblatt, Lisa.

Afiliación

Chow D; Hawaii Center for AIDS, John A. Burns School of Medicine, University of Hawaii Manoa, Honolulu, HI, USA. dominicc@hawaii.edu.
Shikuma C; Hawaii Center for AIDS, John A. Burns School of Medicine, University of Hawaii Manoa, Honolulu, HI, USA.
Ritchings C; Bristol-Myers Squibb, Plainsboro, NJ, USA.
Guo M; Bristol-Myers Squibb, Plainsboro, NJ, USA.
Rosenblatt L; Bristol-Myers Squibb, Plainsboro, NJ, USA.

Infect Dis Ther ; 5(4): 473-489, 2016 Dec.

Article en En | MEDLINE | ID: mdl-27677263

Palabras clave

Antiretroviral therapy; Atazanavir; Atherosclerosis; Cardiovascular disease; Carotid intima-media thickness; Endothelial function; Flow-mediated dilation; HIV; cIMT

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Qualitative_research / Risk_factors_studies / Systematic_reviews Idioma: En Revista: Infect Dis Ther Año: 2016 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google